{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:59:45Z","timestamp":1792605585457,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Diagnostic Pathology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.semdp.2025.150975","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T16:07:52Z","timestamp":1764259672000},"page":"150975","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Multiple Myeloma: A Structured and Multidisciplinary Approach to Diagnosis"],"prefix":"10.1016","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-1330-4782","authenticated-orcid":false,"given":"Nourhan","family":"Ibrahim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janhavi","family":"Govande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda","family":"Mai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.semdp.2025.150975_bib0001","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1002\/ajh.26590","article-title":"Multiple myeloma: 2022 update on diagnosis, risk stratification, and management","volume":"97","author":"Rajkumar","year":"2022","journal-title":"Am J Hematol"},{"key":"10.1016\/j.semdp.2025.150975_bib0002","first-page":"33","article-title":"Differential diagnosis and therapeutic advances in multiple myeloma: a review article","volume":"13","author":"Hussain","year":"2023","journal-title":"Blood Lymphat Cancer"},{"key":"10.1016\/j.semdp.2025.150975_bib0003","series-title":"StatPearls","article-title":"Monoclonal gammopathy of undetermined significance","author":"Kaseb","year":"2025"},{"key":"10.1016\/j.semdp.2025.150975_bib0004","doi-asserted-by":"crossref","first-page":"124","DOI":"10.12659\/AJCR.892837","article-title":"POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes) treated with autologous hematopoietic stem cell transplantation: a case report and literature review","volume":"16","author":"Arana","year":"2015","journal-title":"Am J Case Rep"},{"key":"10.1016\/j.semdp.2025.150975_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.101910","article-title":"SLiM CRAB criteria revisited: temporal trends in prognosis of patients with smoldering multiple myeloma who meet the definition of 'biomarker-defined early multiple myeloma'-a systematic review with meta-analysis","volume":"58","author":"Ludwig","year":"2023","journal-title":"EClinicalMedicine"},{"issue":"1","key":"10.1016\/j.semdp.2025.150975_bib0006","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1053\/j.seminoncol.2022.01.007","article-title":"Modern radiographic imaging in multiple myeloma, what is the minimum requirement?","volume":"49","author":"Mena","year":"2022","journal-title":"Semin Oncol"},{"issue":"6","key":"10.1016\/j.semdp.2025.150975_bib0007","first-page":"421","article-title":"FDG PET imaging in multiple myeloma: implications for response assessments in clinical trials","volume":"8","author":"Sundaram","year":"2018","journal-title":"Am J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1016\/j.semdp.2025.150975_bib0008","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3390\/jcm13010264","article-title":"Imaging of Multiple myeloma: present and future","volume":"13","author":"Rodr\u00edguez-Laval","year":"2024","journal-title":"J Clin Med"},{"issue":"2","key":"10.1016\/j.semdp.2025.150975_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.sjbs.2023.103920","article-title":"An overview of multiple myeloma: a monoclonal plasma cell malignancy's diagnosis, management, and treatment modalities","volume":"31","author":"Abduh","year":"2024","journal-title":"Saudi J Biol Sci"},{"key":"10.1016\/j.semdp.2025.150975_bib0010","doi-asserted-by":"crossref","first-page":"34","DOI":"10.12703\/r\/11-34","article-title":"Monoclonal gammopathy of undetermined significance: evaluation, risk assessment, management, and beyond","volume":"11","author":"Abeykoon","year":"2022","journal-title":"Fac Rev"},{"issue":"1","key":"10.1016\/j.semdp.2025.150975_bib0011","first-page":"76","article-title":"A study on free light chain assay and serum immunofixation electrophoresis for the diagnosis of monoclonal gammopathies","volume":"34","author":"Kuriakose","year":"2019","journal-title":"Indian J Clin Biochem"},{"issue":"4","key":"10.1016\/j.semdp.2025.150975_bib0012","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/j.1365-2141.2008.07369.x","article-title":"Diagnostic performance of serum free light chain measurement in patients suspected of a monoclonal B-cell disorder","volume":"143","author":"Vermeersch","year":"2008","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.semdp.2025.150975_bib0013","doi-asserted-by":"crossref","first-page":"e5116","DOI":"10.1002\/jms.5116","article-title":"Mass spectrometry-based proteomics in clinical diagnosis of amyloidosis and multiple myeloma: a review (2012-2024)","volume":"60","author":"Kratka","year":"2025","journal-title":"J Mass Spectrom"},{"issue":"6","key":"10.1016\/j.semdp.2025.150975_bib0014","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1158\/1078-0432.CCR-23-2767","article-title":"Monitoring minimal residual disease in patients with multiple myeloma by targeted tracking serum M-protein using mass spectrometry (EasyM)","volume":"30","author":"Fan","year":"2024","journal-title":"Clin Cancer Res"},{"issue":"5","key":"10.1016\/j.semdp.2025.150975_bib0015","doi-asserted-by":"crossref","first-page":"743","DOI":"10.3390\/jpm13050743","article-title":"Laboratory and clinical settings of heavy\/light chain (HLC) assays in the management of monoclonal gammopathies and multiple myeloma","volume":"13","author":"Napodano","year":"2023","journal-title":"J Pers Med"},{"issue":"2","key":"10.1016\/j.semdp.2025.150975_bib0016","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1182\/blood-2017-09-807560","article-title":"How I manage monoclonal gammopathy of undetermined significance","volume":"131","author":"Ronald","year":"2018","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.semdp.2025.150975_bib0017","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/s41408-023-00806-w","article-title":"Multiple myeloma with acute light chain cast nephropathy","volume":"13","author":"Leung","year":"2023","journal-title":"Blood Cancer J"},{"issue":"4","key":"10.1016\/j.semdp.2025.150975_bib0018","first-page":"233","article-title":"Anemia in multiple myeloma","volume":"2","author":"Ludwig","year":"2004","journal-title":"Clin Adv Hematol Oncol"},{"issue":"3","key":"10.1016\/j.semdp.2025.150975_bib0019","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1158\/1078-0432.CCR-07-2063","article-title":"The prognostic significance of serum beta2 microglobulin levels in acute myeloid leukemia and prognostic scores predicting survival: analysis of 1180 patients","volume":"14","author":"Tsimberidou","year":"2008","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.semdp.2025.150975_bib0020","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00277-022-04771-5","article-title":"Monitoring multiple myeloma in the peripheral blood based on cell-free DNA and circulating plasma cells","volume":"101","author":"Mack","year":"2022","journal-title":"Ann Hematol"},{"issue":"3","key":"10.1016\/j.semdp.2025.150975_bib0021","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.blre.2011.01.005","article-title":"Plasma cell leukemia","volume":"25","author":"Albarracin","year":"2011","journal-title":"Blood Rev"},{"key":"10.1016\/j.semdp.2025.150975_bib0022","series-title":"StatPearls","article-title":"Multiple myeloma","author":"Albagoush","year":"2025"},{"key":"10.1016\/j.semdp.2025.150975_bib0023","series-title":"StatPearls","article-title":"Histology, plasma cells","author":"Allen","year":"2025"},{"issue":"12","key":"10.1016\/j.semdp.2025.150975_bib0024","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/j.humpath.2007.04.010","article-title":"Assessment of bone marrow plasma cell infiltrates in multiple myeloma: the added value of CD138 immunohistochemistry","volume":"38","author":"Al-Quran","year":"2007","journal-title":"Hum Pathol"},{"issue":"12","key":"10.1016\/j.semdp.2025.150975_bib0025","first-page":"1101","article-title":"CD138\/syndecan-1: a useful immunohistochemical marker of normal and neoplastic plasma cells on routine trephine bone marrow biopsies","volume":"12","author":"Chilosi","year":"1999","journal-title":"Mod Pathol"},{"issue":"6","key":"10.1016\/j.semdp.2025.150975_bib0026","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1182\/blood.V95.6.2084","article-title":"A monoclonal antibody (MUM1p) detects expression of the MUM1\/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cells [published correction appears in Blood. 2013 Oct 3;122(14):2523]","volume":"95","author":"Falini","year":"2000","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.semdp.2025.150975_bib0027","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.beha.2010.09.002","article-title":"Immunophenotyping in multiple myeloma and related plasma cell disorders","volume":"23","author":"Kumar","year":"2010","journal-title":"Best Pract Res Clin Haematol"},{"issue":"10","key":"10.1016\/j.semdp.2025.150975_bib0028","doi-asserted-by":"crossref","first-page":"e617","DOI":"10.1038\/bcj.2017.90","article-title":"Current applications of multiparameter flow cytometry in plasma cell disorders","volume":"7","author":"Jelinek","year":"2017","journal-title":"Blood Cancer J"},{"issue":"1","key":"10.1016\/j.semdp.2025.150975_bib0029","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1002\/hem3.32","article-title":"CDK6 protein expression is associated with disease progression and treatment resistance in multiple myeloma","volume":"8","author":"Steinhart","year":"2024","journal-title":"Hemasphere"},{"issue":"14","key":"10.1016\/j.semdp.2025.150975_bib0030","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.3390\/cancers15143687","article-title":"Minimal residual disease in multiple myeloma: past, present, and future","volume":"15","author":"Medina-Herrera","year":"2023","journal-title":"Cancers (Basel)."},{"key":"10.1016\/j.semdp.2025.150975_bib0031","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41408-024-01102-x","article-title":"Measurable residual disease (MRD) dynamics in multiple myeloma and the influence of clonal diversity analyzed by artificial intelligence","volume":"14","author":"Martinez-Lopez","year":"2024","journal-title":"Blood Cancer J"},{"issue":"10","key":"10.1016\/j.semdp.2025.150975_bib0032","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1038\/leu.2017.29","article-title":"Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma","volume":"31","author":"Flores-Montero","year":"2017","journal-title":"Leukemia"}],"container-title":["Seminars in Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S074025702500111X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S074025702500111X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T07:50:17Z","timestamp":1768549817000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S074025702500111X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S074025702500111X"],"URL":"https:\/\/doi.org\/10.1016\/j.semdp.2025.150975","relation":{},"ISSN":["0740-2570"],"issn-type":[{"value":"0740-2570","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multiple Myeloma: A Structured and Multidisciplinary Approach to Diagnosis","name":"articletitle","label":"Article Title"},{"value":"Seminars in Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semdp.2025.150975","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"150975"}}